Atlas Trials

Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT

Clinical trial NCT02962167 · COMPLETED

Trial details

NCT number
NCT02962167
Sponsor
Sabine Mueller, MD, PhD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Medulloblastoma, Childhood, RecurrentAtypical Teratoid/Rhabdoid TumorMedulloblastoma Recurrent
Start date
2017-02-22
Primary completion
2023-05-10
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.